Company Data
Galapagos NV
Ticker
GLPG
Current Price
$33.92 -0.53%
Market Cap
$2.2B
Price Target
Refer to Report
Volume
320.1K
52wk Range
$22.36 - $37.78
Overview
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company’s product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn’s disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.